Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by canadapieton Jan 11, 2019 12:20pm

205 Views

Post# 29219253

to lie

If things are setting up the way some competent people here are predicting, and it happens fast (let's say within 6 months), then it is really a criminal behavior and that Mackie analist should be put in jail!!

I think the bottom is in now for sure, and the bounce of the low on volume is pretty good and hopefull!!

I hope the trend MR. SPCEO is seeing is just the beginning of a leg up for the rest of the year :-) !!

Dubbeled my holdings.

Good l a

Bullboard Posts

Canada Nickel unveils second of seven resources planned by mid-2025